All vendors

Carolina Infusion

ActivePrescription Required
United States
US

FDA Class II Recall D-1518-2022 for Sermorelin Acetate injectables; reason: lack of assurance of sterility; distributed nationwide; FDA site inspection conducted.

Testing and trust

Third-party COA

No

Reputation

Community trust

No community trust assessment available — this is an FDA enforcement record only.

Reported issues

  • •Closed (August 2022)

Reported issues describe what our data shows. They are not a legal finding.

Is this your company? Claim this listing to correct your details and connect your store.

Claim listing

For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.